This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DIBUCAINE OINTMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract is for the procurement of DIBUCAINE OINTMENT, USP, which contains 1 percent dibucaine as the active ingredient. The ointment is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration and external use only. Each unit consists of a one-ounce (28 grams) package with a total shelf life of 36 months, and a minimum of 31 months shelf life is required at the time of receipt by the first government activity. The product must be stored between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit) and labeled with essential information including the National Stock Number, manufacturer details, manufacturing and expiration dates, contract number, and lot number. Packaging requirements mandate commercial packaging suitable for safe transport and handling, including sealed unit containers and appropriate exterior shipping containers compliant with Medical Marking Standard No.1. The contract specifies that items must be delivered to the destination within 20 days without quantity variance, with acceptance and inspection points also at the destination. This procurement, under solicitation number SPE2DP-26-T-3437, involves a total order quantity of 15 packages and is managed by the Department of Defense Medical Supply Chain Pharmacy FSA, with delivery to Fort Bragg. The contract also references adherence to quality and technical standards listed in the DLA Master List of Technical and Quality Requirements and includes procedures for FDA regulation compliance and government identification removal from non-accepted supplies.
General Info
Agency
NAICS
Place of Performance
5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
DIBUCAINE OINTMENT,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT
.
COMES SUPPLIED IN A COLLAPSIBLE TUBE
AND RECTAL APPLICATOR
.
RECTALLY ADMINISTERED
.
FOR EXTERNAL USE ONLY
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
ONE (1) OUNCE OR 28 GRAMS
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT
BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 15-30 DEGREES CELSIUS OR
59 TO 86 DEGREES FARENHEIT
.
LABELING AND MARKING:
MUST INCLUDE THE FOLLOWING:
NATIONAL STOCK NUMBER,
MANUFACTURER,
DATE OF MANUFACTURER,
EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER
AND LOT NUMBER
.
1/7/2015
1 PG = 28 GM
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
SPE2DP-26-T-3437
SECTION B
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016803175 0001 PG 15.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-299-9535 Quantity: 15 PG Purchase Request: 7016803175QTY: 15 Delivery: 20 days ADO
